Decisions come at you fast when you have stock compensation. Year-start, before tax season begins, is a great time to make a ...

Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into ...

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today ...

The options have an exercise price of $7.90 per share, which is equal to the closing price of BioCryst common stock on the ...

The value of a Wall Street bonus at the time of the award often ends up being far different than what bankers collect several ...

Richard C. Malabre, the Senior Vice President and Chief Accounting Officer of Akebia Therapeutics, Inc. (NASDAQ:AKBA), recently sold a portion of his holdings in the company. The transaction comes as ...

William E. Rote, Senior Vice President of Research and Development at Travere Therapeutics, Inc. (NASDAQ:TVTX), recently sold a portion of his holdings in the company. According to a recent SEC filing ...

TORONTO, Jan. 13, 2025 (GLOBE NEWSWIRE) — Premier American Uranium Inc. (“PUR”, the “Company” or “Premier”) (TSXV: PUR) (OTCQB: PAUIF) announces that it ...

announces that it has granted 640,000 incentive stock options (the “Options”) and 33,333 restricted share units (“RSUs”) to certain directors, officers, consultants and advisors of the ...

Our program offers a personalized guide through the unique financial challenges of a tech career—whether its managing stock options, understanding restricted stock units (RSUs), allocating long ...